Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Clin Psychopharmacol ; 40(3): 297-299, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32332466

RESUMO

BACKGROUND: Anxiety is a common and invalidating symptom of dementia with Lewy bodies (DLB). METHODS: To evaluate the efficacy of pregabalin as a treatment for anxiety in DLB, we screened all medical files of our patients with DLB for the use of pregabalin in this context. FINDINGS: Overall, pregabalin was well tolerated. Ten (62.5%) of 16 patients showed an improvement of anxiety, whereas in 3 of them, anxiety disappeared completely, at respectively 3, 11, and 22 months of follow-up, with total daily doses ranging from 75 to 150 mg. Positive response to pregabalin was associated with a significant reduction in benzodiazepine use. CONCLUSIONS: Pregabalin seems a useful and safe tool for treating anxiety in patients with DLB.


Assuntos
Ansiedade/tratamento farmacológico , Doença por Corpos de Lewy/tratamento farmacológico , Pregabalina/uso terapêutico , Idoso , Idoso de 80 Anos ou mais , Ansiolíticos/uso terapêutico , Ansiedade/complicações , Feminino , Humanos , Doença por Corpos de Lewy/complicações , Masculino , Estudos Retrospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...